Agreed - why would you be selling at these levels when they have a profitable business, are STILL trading at or just above cash backing and have indicated are looking at doing deals!
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%